This paper is in the following e-collection/theme issue:

Genome Analysis and Visualization (14) JMIR Theme Issue: COVID-19 Special Issue (2452) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517) Outbreak and Pandemic Preparedness and Management (1727) Infectious Diseases (non-STD/STI) (1575) Clinical Informatics (1022) Genomics and Bioinformatics for Clinical Use (35)

Published on in Vol 3, No 1 (2022): Jan-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31536, first published .
The Easy-to-Use SARS-CoV-2 Assembler for Genome Sequencing: Development Study

The Easy-to-Use SARS-CoV-2 Assembler for Genome Sequencing: Development Study

The Easy-to-Use SARS-CoV-2 Assembler for Genome Sequencing: Development Study

Authors of this article:

Martina Rueca1 Author Orcid Image ;   Emanuela Giombini1 Author Orcid Image ;   Francesco Messina2 Author Orcid Image ;   Barbara Bartolini2 Author Orcid Image ;   Antonino Di Caro2, 3 Author Orcid Image ;   Maria Rosaria Capobianchi1, 3 Author Orcid Image ;   Cesare EM Gruber1 Author Orcid Image
Article Authors Cited by (7) Tweetations (2) Metrics

Journals

  1. Rueca M, Giombini E, Gramigna G, Gruber C, Fabeni L, Corpolongo A, Mazzotta V, Corso L, Butera O, Valli M, Carletti F, Pignalosa S, Vairo F, Nicastri E, Antinori A, Girardi E, Vaia F, Maggi F. Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy. Diagnostics 2022;12(9):2219 View
  2. Berno G, Fabeni L, Matusali G, Gruber C, Rueca M, Giombini E, Garbuglia A. SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods. Pathogens 2022;11(9):1058 View
  3. Mugnier N, Griffon A, Simon B, Rambaud M, Regue H, Bal A, Destras G, Tournoud M, Jaillard M, Betraoui A, Santiago E, Cheynet V, Vignola A, Ligeon V, Josset L, Brengel-Pesce K. Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches. Viruses 2022;14(8):1674 View
  4. Gruber C, Tucci F, Rueca M, Mazzotta V, Gramigna G, Vergori A, Fabeni L, Berno G, Giombini E, Butera O, Focosi D, Prandi I, Chillemi G, Nicastri E, Vaia F, Girardi E, Antinori A, Maggi F. Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients. Biomolecules 2023;13(10):1538 View
  5. Rueca M, Berno G, Agresta A, Spaziante M, Gruber C, Fabeni L, Giombini E, Butera O, Barca A, Scognamiglio P, Girardi E, Maggi F, Valli M, Vairo F. Genomic and Epidemiologic Surveillance of SARS-CoV-2 in the Pandemic Period: Sequencing Network of the Lazio Region, Italy. Viruses 2023;15(11):2192 View
  6. Gruber C, Tucci F, Giombini E, Mazzotta V, Spezia P, Rueca M, Mastrorosa I, Fabeni L, Berno G, Butera O, Rosati S, Specchiarello E, Carletti F, Focosi D, Nicastri E, Girardi E, Antinori A, Maggi F. Molnupiravir increases SARS‐CoV‐2 genome diversity and complexity: A case‐control cohort study. Journal of Medical Virology 2024;96(5) View
  7. Mazzotta V, Mazzaferri F, Lanini S, Mirandola M, Cozzi Lepri A, Vergori A, Savoldi A, Santoro A, Maccarrone G, Mastrorosa I, Simonetti O, Zottis F, Nicastri E, Rosini G, Rovigo L, Tavernaro L, Sarmati L, Tascini C, Girardi E, Cattelan A, Antinori A, Tacconelli E. Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves. Journal of Infection 2024;89(5):106294 View